An IL-2 Protein Therapeutic for Cancer that Gains Function on the Spot.
Sign Up to like & getrecommendations! Published in 2022 at "Cancer immunology research"
DOI: 10.1158/2326-6066.cir-22-0186
Abstract: Recombinant human IL-2 (rhIL-2) is now rarely used to treat patients with cancer because it too often causes severe toxicities. In this issue, Nirschl and colleagues report the development and preclinical characterization of an engineered… read more here.
Keywords: cancer gains; protein therapeutic; function spot; therapeutic cancer ... See more keywords